Search Results - "Weström, S."

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation by Tobiasson, Magnus, Pandzic, Tatjana, Illman, Johanna, Nilsson, Lars, Weström, Simone, Ejerblad, Elisabeth, Olesen, Gitte, Björklund, Andreas, Olsnes Kittang, Astrid, Werlenius, Olle, Lorentz, Fryderyk, Rasmussen, Bengt, Cammenga, Jörg, Weber, Duruta, Lindholm, Carolin, Wiggh, Joel, Dimitriou, Marios, Moen, Ann Elin, Yip Lundström, Laimei, von Bahr, Lena, Baltzer-Sollander, Karin, Jädersten, Martin, Kytölä, Soili, Walldin, Gunilla, Ljungman, Per, Groenbaek, Kirsten, Mielke, Stephan, Jacobsen, Sten Eirik W, Ebeling, Freja, Cavelier, Lucia, Smidstrup Friis, Lone, Dybedal, Ingunn, Hellström-Lindberg, Eva

“…Clinical relapse is the major threat for patients with myelodysplastic syndrome (MDS) undergoing hematopoietic stem-cell transplantation (HSCT). Early…”
Get full text

Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions by Hagforsen, E., Lampinen, M., Paivandy, A., Weström, S., Velin, H., Öberg, S., Pejler, G., Rollman, O.

“…Summary Background Skin mast cells are implicated as detrimental effector cells in various inflammatory skin diseases such as contact eczema, atopic dermatitis…”
Get full text

S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B by Tobiasson, M., Pandzic, T., Illman, J., Nilsson, L., Weström, S., Sollander, K., Ejerblad, E., Olsnes Kittang, A., Olesen, G., Werlenius, O., Björklund, A., Wiggh, J., lindholm, C., Lorentz, F., Rasmussen, B., Cammenga, J., Weber, D., Grönnås, D., Dimitriou, M., Kytölä, S., Walldin, G., Ljungman, P., Groenbeck, K., Mielke, S., Jacobsen, S. E., Ebeling, F., Cavelier, L., Smidstrup Friis, L., Dybedal, I., Hellström‐Lindberg, E.

Get full text

Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions by Hagforsen, E., Lampinen, M., Paivandy, A., Weström, S., Velin, H., Öberg, S., Pejler, G., Rollman, O.

Get full text

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib by Bonfiglio, Silvia, Sutton, Lesley-Ann, Ljungström, Viktor, Capasso, Antonella, Pandzic, Tatjana, Weström, Simone, Foroughi-Asl, Hassan, Skaftason, Aron, Gellerbring, Anna, Lyander, Anna, Gandini, Francesca, Gaidano, Gianluca, Trentin, Livio, Bonello, Lisa, Reda, Gianluigi, Bödör, Csaba, Stavroyianni, Niki, Tam, Constantine S., Marasca, Roberto, Forconi, Francesco, Panayiotidis, Panayiotis, Ringshausen, Ingo, Jaksic, Ozren, Frustaci, Anna Maria, Iyengar, Sunil, Coscia, Marta, Mulligan, Stephen P., Ysebaert, Loïc, Strugov, Vladimir, Pavlovsky, Carolina, Walewska, Renata, Österborg, Anders, Cortese, Diego, Ranghetti, Pamela, Baliakas, Panagiotis, Stamatopoulos, Kostas, Scarfò, Lydia, Rosenquist, Richard, Ghia, Paolo

“…•One-third of patients with CLL relapsing on ibrutinib do not carry BTK/PLCG2 mutations, even with a 0.1% sensitivity.•Additional mechanisms, such as del(8p),…”
Get full text

210P Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays by Chen, L., Eriksson, A., Weström, S., Pandzic, T., Lehmann, S., Cavelier, L., Landegren, U.

Get full text

107P Ultra-sensitive monitoring mutations in cancer patients using superRCA mutation detection assays by Chen, L., Weström, S., Eriksson, A., Pandzic, T., Lehmann, S., Cavelier, L., Landegren, U.

Get full text

629P Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays by Chen, L., Eriksson, A., Weström, S., Pandzic, T., Lehmann, S., Cavelier, L., Landegren, U.

Get full text

Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays by Chen, Lei, Eriksson, Anna, Weström, Simone, Pandzic, Tatjana, Lehmann, Sören, Cavelier, Lucia, Landegren, Ulf

“…Rare tumor-specific mutations in patient samples serve as excellent markers to monitor the course of malignant disease and responses to therapy in clinical…”
Get full text

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS by Lindholm, C., Tobiasson, M., Pandzic, T., Illman, J., Nilsson, L., Weström, S., Ejerblad, E., Olesen, G., Björklund, A., Kittang, A. Olsnes, Werlenius, O., Wiggh, J., Lorentz, F., Rasmussen, B., Cammenga, J., Weber, D., Moen, A.E., Lundström, L.Y., Bahr, L. Von, Dimitriou, M., Kytölä, S., Walldin, G., Ljungman, P., Groenbaek, K., Mielke, S., Jacobsen, S.E., Ebeling, F., Cavelier, L., Friis, L. Smidstrup, Dybedal, I., Hellstrom-Lindberg, E.

Get full text

118 Quantitative analysis of immunofluorescence and in situ PLA staining using CellProfiler reveals impaired epidermal lipid processing pathway in ARCI patients with CYP4F22 mutations by Zhang, H., Virtanen, M., Weström, S., Bygum, A., Wählby, C., Vahlquist, A., Törmä, H.

Get full text

SYSTOLIC BLOOD PRESSURE AND TREATMENT OUTCOMES IN CHRONIC HEART FAILURE by Kim, Keun-Suh, Reddy, Venkataramana, Petersen, DK, Westrom, S, Chiong, Jun R

Get full text

Picky Eating as a Degree instead of Binary Choice by Westrom, S., Hilliard, E.

Get full text

OBESITY PARADOX IN HEART FAILURE: IS IT THE ACCUMULATION OR THE MEDICATION? by Reddy, Venkataramana K, Chiong, Jun R, Kim, K, Westrom, S, Petersen, D

Get full text

Complementary Food Acceptance and Picky Eating by Westrom, S., Woods, R., Hilliard, E.

Get full text

Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation by Roth, Lise, Prahst, Claudia, Ruckdeschel, Tina, Savant, Soniya, Weström, Simone, Fantin, Alessandro, Riedel, Maria, Héroult, Mélanie, Ruhrberg, Christiana, Augustin, Hellmut G

“…Neuropilin-1 (NRP1) regulates developmental and pathological angiogenesis, arteriogenesis, and vascular permeability, acting as a coreceptor for semaphorin 3A…”
Get more information

Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation by Jädersten, Martin, Boriskina, Ksenia, Lindholm, Carolin, Weström, Simone, Cavelier, Lucia, Hellström-Lindberg, Eva, Mielke, Stephan, Tobiasson, Magnus

Get full text

COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROWAND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS by Lindholm, C, Tobiasson, M, Pandzic, T, Illman, J, Nilsson, L, Westrom, S, Ejerblad, E, Olesen, G, Bjorklund, A, Kittang, AO, Werlenius, O, Wiggh, J, Lorentz, F, Rasmussen, B, Cammenga, J, Weber, D, Moen, AE, Lundstrom, LY, Von Bahr, L, Dimitriou, M, Kytola, S, Walldin, G, Ljungman, P, Groenbaek, K, Mielke, S, Jacobsen, SE, Ebeling, F, Cavelier, L, Friis, LS, Dybedal, I, Hellstrom-Lindberg, E

Get full text

Entrapment in phospholipid vesicles quenches photoactivity of quantum dots by Generalov, Roman, Kavaliauskiene, Simona, Westrøm, Sara, Chen, Wei, Kristensen, Solveig, Juzenas, Petras

“…Quantum dots have emerged with great promise for biological applications as fluorescent markers for immunostaining, labels for intracellular trafficking, and…”
Get full text

"Spirals" and acute salpingitis by Bengtsson, S P, Mårdh, P A, Weström, S

Get more information